KRAS and colorectal carcinoma: In the context of CRC initiation and progression, the inactivation of tumor suppressor genes, like P53 and adenomatous polyposis coli (APC), and the activation of oncogenes, such as the Kirsten rat sarcoma viral oncogene homolog (KRAS), is crucial [2].